Invesco
ERAS icon

Invesco’s Erasca ERAS Stock Holding History

Invesco’s Portfolio ERAS Stock Details ERAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.3M Buy
759,932
+430,137
+130% +$5.08M ﹤0.01% 1726
2025
Q4 		$1.23M Buy
329,795
+47,770
+17% +$134K ﹤0.01% 2820
2025
Q3 		$615K Buy
282,025
+109,799
+64% +$175K ﹤0.01% 3148
2025
Q2 		$219K Buy
172,226
+58,643
+52% +$78.5K ﹤0.01% 3492
2025
Q1 		$156K Buy
113,583
+64,912
+133% +$111K ﹤0.01% 3563
2024
Q4 		$122K Buy
48,671
+11,290
+30% +$31K ﹤0.01% 3601
2024
Q3 		$102K Buy
37,381
+4,570
+14% +$12.9K ﹤0.01% 3622
2024
Q2 		$77.4K Buy
32,811
+3,557
+12% +$7.67K ﹤0.01% 3779
2024
Q1 		$60.3K Sell
29,254
-2,544
-8% -$5.08K ﹤0.01% 3791
2023
Q4 		$67.7K Buy
31,798
+7,913
+33% +$16.7K ﹤0.01% 3729
2023
Q3 		$47.1K Buy
23,885
+1,974
+9% +$5.06K ﹤0.01% 3801
2023
Q2 		$60.5K Sell
21,911
-957
-4% -$2.73K ﹤0.01% 3802
2023
Q1 		$68.8K Buy
22,868
+214
+0.9% +$778 ﹤0.01% 3735
2022
Q4 		$97.6K Sell
22,654
-127
-0.6% -$861 ﹤0.01% 3831
2022
Q3 		$178K Sell
22,781
-198
-0.9% -$1.59K ﹤0.01% 3716
2022
Q2 		$128K Buy
22,979
+6,423
+39% +$42K ﹤0.01% 3842
2022
Q1 		$143K Buy
16,556
+5,809
+54% +$67.3K ﹤0.01% 3828
2021
Q4 		$167K Buy
+10,747
New +$184K ﹤0.01% 3820

Other funds holding ERAS

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Invesco's ERAS Position: Q1 2026 in Review

Invesco increased its Erasca (ERAS) stake by 130% in Q1 2026, buying an estimated $5.08M and bringing the position to 759,932 shares worth $12.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1726.

Invesco first reported a position in ERAS in Q4 2021 and has held it in 18 quarters since. 225 funds tracked by Wall St. Rank hold ERAS as of Q1 2026.

  • Invesco held 759,932 shares of Erasca worth $12.3M as of Q1 2026.
  • Invesco bought 430,137 Erasca shares in Q1 2026, an estimated $5.08M.
  • Erasca made up ﹤0.01% of Invesco's portfolio in Q1 2026, its #1726 holding.
  • Invesco first reported a position in Erasca in Q4 2021 and has held it in 18 quarters since.
  • 225 funds tracked by Wall St. Rank held Erasca as of Q1 2026.

Based on Invesco's 13F filing for Q1 2026, filed 12 May 2026.